"Global Medical Cannabis Market Overview:
Global Medical Cannabis Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Medical Cannabis Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Medical Cannabis involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Medical Cannabis Market:
The Medical Cannabis Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Medical Cannabis Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Medical Cannabis Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Medical Cannabis market has been segmented into:
Cannabis Indica
Sativa
Hybrid
By Application, Medical Cannabis market has been segmented into:
Research And Development Centers
Pharmaceutical
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Medical Cannabis market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Medical Cannabis market.
Top Key Players Covered in Medical Cannabis market are:
BOL Pharma
Tilray
Medreleaf Corporation
Aurora Cannabis
Inc.
Canopy Growth Corporation
Insys Therapeutics
Inc.
Aphria
Inc.
MGC Pharmaceuticals Limited.
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Medical Cannabis Market by Type
4.1 Medical Cannabis Market Snapshot and Growth Engine
4.2 Medical Cannabis Market Overview
4.3 Cannabis Indica
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Cannabis Indica: Geographic Segmentation Analysis
4.4 Sativa
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Sativa: Geographic Segmentation Analysis
4.5 Hybrid
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Hybrid: Geographic Segmentation Analysis
Chapter 5: Medical Cannabis Market by Application
5.1 Medical Cannabis Market Snapshot and Growth Engine
5.2 Medical Cannabis Market Overview
5.3 Research And Development Centers
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Research And Development Centers: Geographic Segmentation Analysis
5.4 Pharmaceutical
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Pharmaceutical: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Medical Cannabis Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 BOL PHARMA
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 TILRAY
6.4 MEDRELEAF CORPORATION
6.5 AURORA CANNABIS
6.6 INC.
6.7 CANOPY GROWTH CORPORATION
6.8 INSYS THERAPEUTICS
6.9 INC.
6.10 APHRIA
6.11 INC.
6.12 MGC PHARMACEUTICALS LIMITED.
Chapter 7: Global Medical Cannabis Market By Region
7.1 Overview
7.2. North America Medical Cannabis Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Cannabis Indica
7.2.4.2 Sativa
7.2.4.3 Hybrid
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Research And Development Centers
7.2.5.2 Pharmaceutical
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Medical Cannabis Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Cannabis Indica
7.3.4.2 Sativa
7.3.4.3 Hybrid
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Research And Development Centers
7.3.5.2 Pharmaceutical
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Medical Cannabis Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Cannabis Indica
7.4.4.2 Sativa
7.4.4.3 Hybrid
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Research And Development Centers
7.4.5.2 Pharmaceutical
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Medical Cannabis Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Cannabis Indica
7.5.4.2 Sativa
7.5.4.3 Hybrid
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Research And Development Centers
7.5.5.2 Pharmaceutical
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Medical Cannabis Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Cannabis Indica
7.6.4.2 Sativa
7.6.4.3 Hybrid
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Research And Development Centers
7.6.5.2 Pharmaceutical
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Medical Cannabis Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Cannabis Indica
7.7.4.2 Sativa
7.7.4.3 Hybrid
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Research And Development Centers
7.7.5.2 Pharmaceutical
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Medical Cannabis Scope:
|
Report Data
|
Medical Cannabis Market
|
|
Medical Cannabis Market Size in 2025
|
USD XX million
|
|
Medical Cannabis CAGR 2025 - 2032
|
XX%
|
|
Medical Cannabis Base Year
|
2024
|
|
Medical Cannabis Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc., Canopy Growth Corporation, Insys Therapeutics, Inc., Aphria, Inc., MGC Pharmaceuticals Limited..
|
|
Key Segments
|
By Type
Cannabis Indica
Sativa
Hybrid
By Applications
Research And Development Centers
Pharmaceutical
|
